Dortmund and Berlin, Germany, February 21, 2011: Scienion AG announced today that EUROIMMUN AG – one of the leading manufacturers of immuno-biochemical assays – has purchased Scienion’s sciFLEXARRAYER technology to develop multiplexed diagnostic products and to produce new test formats.
EUROIMMUN is one of the world’s leading manufacturers of medical laboratory diagnostics with a focus on test systems for the determination of various antibodies in patient serum in the diagnosis of autoimmune diseases, infectious diseases and allergies.
Dr. Ulf Steller, Head of Microarray Division at EUROIMMUN AG, gives several reasons for choosing Scienion’s sciFLEXARRAYER: “Having compared different dispensers, we regard the sciFLEXARRAYER family as the most advanced DNA and protein printing systems currently available. Performing extensive pilot studies at Scienion convinced us of the technology and was a great aid in taking this important decision.
Dr. Holger Eickhoff, CEO of Scienion AG, states: “Dispensing and deposition of reagents in the picoliter to nanoliter range has become crucial for Next-Generation Diagnostic Products. Scienion is well-positioned to enable the dispensing of any kind of content to any kind of surface and this is a strategic advantage for the continuously growing market of multiplexed assays in the in-vitro diagnostics (IVD) field.
© 2013 TechnologieZentrumDortmund GmbH - Emil-Figge-Straße 76-80 - 44227 Dortmund